6.
Saadi I, Alkuraya F, Gisselbrecht S, Goessling W, Cavallesco R, Turbe-Doan A
. Deficiency of the cytoskeletal protein SPECC1L leads to oblique facial clefting. Am J Hum Genet. 2011; 89(1):44-55.
PMC: 3135813.
DOI: 10.1016/j.ajhg.2011.05.023.
View
7.
Zhang Z, Liu X, Zhang S, Song Z, Lu K, Yang W
. A review and analysis of key biomarkers in Alzheimer's disease. Front Neurosci. 2024; 18:1358998.
PMC: 10912539.
DOI: 10.3389/fnins.2024.1358998.
View
8.
McGeer P, McGeer E, Yasojima K
. Alzheimer disease and neuroinflammation. J Neural Transm Suppl. 2000; 59:53-7.
DOI: 10.1007/978-3-7091-6781-6_8.
View
9.
Mastroeni D, Chouliaras L, Grover A, Liang W, Hauns K, Rogers J
. Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer's disease pathophysiology. PLoS One. 2013; 8(1):e53349.
PMC: 3540085.
DOI: 10.1371/journal.pone.0053349.
View
10.
Tsai C, Kim J, Li X, Czarnewski P, Li R, Meng F
. Hippo-deficient cardiac fibroblasts differentiate into osteochondroprogenitors. bioRxiv. 2024; .
PMC: 10962739.
DOI: 10.1101/2023.09.06.556593.
View
11.
Piehowski P, Petyuk V, Orton D, Xie F, Moore R, Ramirez-Restrepo M
. Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. J Proteome Res. 2013; 12(5):2128-37.
PMC: 3695475.
DOI: 10.1021/pr301146m.
View
12.
Bu Y, Lederer J
. Integrating additional knowledge into the estimation of graphical models. Int J Biostat. 2021; 18(1):1-17.
DOI: 10.1515/ijb-2020-0133.
View
13.
Soliman N, Okuse K, Rice A
. VGF: a biomarker and potential target for the treatment of neuropathic pain?. Pain Rep. 2019; 4(5):e786.
PMC: 6882576.
DOI: 10.1097/PR9.0000000000000786.
View
14.
Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C
. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45(12):1452-8.
PMC: 3896259.
DOI: 10.1038/ng.2802.
View
15.
von Bernhardi R, Cornejo F, Parada G, Eugenin J
. Role of TGFβ signaling in the pathogenesis of Alzheimer's disease. Front Cell Neurosci. 2015; 9:426.
PMC: 4623426.
DOI: 10.3389/fncel.2015.00426.
View
16.
Ghiassian S, Menche J, Barabasi A
. A DIseAse MOdule Detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human interactome. PLoS Comput Biol. 2015; 11(4):e1004120.
PMC: 4390154.
DOI: 10.1371/journal.pcbi.1004120.
View
17.
Rodin A, Gogoshin G, Hilliard S, Wang L, Egelston C, Rockne R
. Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data. Int J Mol Sci. 2021; 22(5).
PMC: 7956201.
DOI: 10.3390/ijms22052316.
View
18.
Bennett D, Wilson R, Boyle P, Buchman A, Schneider J
. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012; 72(4):599-609.
PMC: 3490232.
DOI: 10.1002/ana.23654.
View
19.
Jemimah S, AlShehhi A
. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease. BMC Med Genomics. 2023; 16(Suppl 2):244.
PMC: 10571239.
DOI: 10.1186/s12920-023-01675-9.
View
20.
Bhoj E, Haye D, Toutain A, Bonneau D, Nielsen I, Lund I
. Phenotypic spectrum associated with SPECC1L pathogenic variants: new families and critical review of the nosology of Teebi, Opitz GBBB, and Baraitser-Winter syndromes. Eur J Med Genet. 2018; 62(12):103588.
PMC: 6594898.
DOI: 10.1016/j.ejmg.2018.11.022.
View